Consensus Statements

The Consensus Statements on the Care of Patients with Thalassemia and Sickle Cell Disease in Canada represent essential updates in the management of these challenging conditions, incorporating the latest best practices to enhance patient care across the country.

The revised Consensus Statement on Thalassemia updates the 2009 guidelines, providing healthcare professionals with practical and targeted information to improve care delivery and patient outcomes. This document outlines the key members, goals, and functions of a comprehensive Thalassemia care team, offering principles, recommendations, and interventions specific to Thalassemia management and its complications within the Canadian healthcare context.

Similarly, the Consensus Statement on Sickle Cell Disease offers a detailed overview of best practices for managing and preventing complications related to this condition. It serves as a practical guide for Canadian healthcare providers—including hematologists, internists, pediatricians, emergency physicians, and subspecialists—highlighting key principles and recommendations for quick reference. Additionally, this document is designed to support patients and their families by providing valuable information to help them engage effectively in their care and advocate for their needs.

Together, these statements aim to improve the quality of care for patients with Thalassemia and Sickle Cell Disease in Canada by ensuring that both healthcare providers and patients have access to the most relevant and up-to-date guidance.

Consensus Statement

Sickle Cell Disease Consensus Statement

Read Consensus Statement

Consensus Statement

Clinical Care of Patients with Thalassemia in Canada

Read Consensus Statement